The mean(s.d.)time to developing metachronous CRC was 14.3(9.1) years for path_MLH1 carriers, 12.2(8.0) years for path_MSH2 carriers, and 10.2(7.4) years for path_MSH6 carriers. This evidence concerns the gene MSH2 and colorectal carcinoma.